Concepedia

Author

Khyati Meghani

Northwestern UniversityORCID

Also Known As

Khyati A. Meghani, Khyati Meghani

28

Publications

1K

Citations

11

H-Index

27

Concepts

All Affiliations

Northwestern UniversityDana-Farber Cancer InstituteHarvard UniversityJesse Brown VA Medical CenterBroad Institute
KM

About

Khyati Meghani is an author at Northwestern University specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

451

2

Cell Biology

4

4

451

3

Natural Sciences

1

1

123

4

Immunology

1

1

45

5

Molecular Biology

1

1

123

Khyati Meghani

×

11

Publications

980

Citations

11

H-Index

YearCitations

DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells

Yizhou He, Khyati Meghani, Marie‐Christine Caron,

Nature

2018

214

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13

Mei Zeng, Nicholas Kwiatkowski, Tinghu Zhang,

eLife

2018

157

Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer

Young Eun Choi, Khyati Meghani, Marie-Eve Brault,

Cell Reports

2016

139

TIRR regulates 53BP1 by masking its histone methyl-lysine binding function

Pascal Drané, Marie-Eve Brault, Gaofeng Cui,

Nature

2017

123

Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates

Wojciech Fendler, Beata Małachowska, Khyati Meghani,

Science Translational Medicine

2017

86

Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas

Khyati Meghani, Walker Fuchs, Alexandre Detappe,

Cell Reports

2018

69

First-in-human Intravesical Delivery of Pembrolizumab Identifies Immune Activation in Bladder Cancer Unresponsive to Bacillus Calmette-Guérin

Khyati Meghani, Lauren Folgosa Cooley, Bonnie Choy,

European Urology

2022

60

Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer

A. Gordon Robertson, Khyati Meghani, Lauren Folgosa Cooley,

Nature Communications

2023

58

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma

Andrea Piunti, Khyati Meghani, Yanni Yu,

Science Advances

2022

45

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy

Joseph R. Podojil, Andrew C. Cogswell, Ming‐Yi Chiang,

Frontiers in Immunology

2022

15

Page 1